For the year ending 2025-12-31, SANA has $416,890K in assets. $256,006K in debts. $71,870K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 71,870 | |||
| Marketable securities | 66,512 | |||
| Restricted cash | 4,195 | |||
| Prepaid expenses and other current assets | 6,099 | |||
| Total current assets | 148,676 | |||
| Property and equipment, at cost | 81,661 | |||
| Less accumulated depreciation | 54,755 | |||
| Property and equipment, net | 26,906 | |||
| Operating lease right-of-use assets | 38,313 | |||
| Intangible asset | 59,195 | |||
| Goodwill | 140,627 | |||
| Other non-current assets | 3,173 | |||
| Total assets | 416,890 | |||
| Accounts payable | 1,669 | |||
| Accrued compensation | 13,240 | |||
| Accrued expenses and other current liabilities | 8,679 | |||
| Operating lease liabilities | 14,938 | |||
| Contingent consideration | 40,200 | |||
| Total current liabilities | 78,726 | |||
| Operating lease liabilities, net of current portion | 63,924 | |||
| Contingent consideration, net of current portion | 83,518 | |||
| Success payment liabilities | 19,238 | |||
| Other non-current liabilities | 10,600 | |||
| Total liabilities | 256,006 | |||
| Common stock, 0.0001 par value 750,000 shares authorized 266,732 and 223,923 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 27 | |||
| Additional paid-in capital | 2,009,845 | |||
| Accumulated other comprehensive income | 28 | |||
| Accumulated deficit | -1,849,016 | |||
| Total stockholders' equity | 160,884 | |||
| Total liabilities and stockholders' equity | 416,890 | |||
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)